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CHIMERIC ISOPRENOID SYNTHASES AND
USES THEREOF

isoprenoid biosynthetic enZymes and especially those
enZymes involved in catalyZing the cycliZation of various

isoprenoid intermediates (GershenZon and Croteau, In: Lipid
Metabolism in Plants, Moore, T. S., ed., CRC Press, Boca
Raton, Fla., pp. 340—388). The enZymes responsible for the

CROSS REFERENCE TO RELATED
APPLICATION

cycliZation of GPP, FPP, and GGPP are referred to as

This application is a continuation of US. Ser. No. 08/631,

341, ?led Apr. 12, 1996, now US. Pat. No. 5,824,774,

hereby incorporated by reference.
STATEMENT AS TO FEDERALLY SPONSORED
RESEARCH

10

tively.
TWo important biochemical distinctions betWeen the pre
nyltransferase and synthase reactions are illustrated in FIG.

This invention Was made in part With Government

2. The prenyltransferases catalyZe carbon-carbon bond for

funding, and the Government therefore has certain rights in
the invention.

15

BACKGROUND OF THE INVENTION

mation. The prenyltransferases also catalyZe reactions With

ensuing polymer. Prenyltransferases differ in the length of
20

compounds derived from the isoprene building block. In

utiliZe the same substrate to produce different reaction

group of compounds that can be divided into classes of

products.
25

that are primary metabolites include sterols, carotenoids,

groWth regulators, and the polyprenol substituents of
dolichols, quinones, and proteins. These compounds are
essential for membrane integrity, photoprotection, orches
tration of developmental programs, and anchoring essential
biochemical functions to speci?c membrane systems,
respectively. Isoprenoids that are classi?ed as secondary
metabolites include monoterpenes, sesquiterpenes, and
diterpenes. These compounds are said to mediate important
interactions betWeen plants and their environment. For

example, speci?c terpenoids have been correlated With
plant-plant (Stevens, In: Isopentoids in Plants, Nes, W. D.
Fuller, G., and Tsai, L.-S., eds., Marcel Dekker, NeW York,
pp. 65—80, 1984), plant-insect (Gibson and Pickett, Nature
3021608, 1983), and plant-pathogen interactions (Stoessl et

al., Phytochemistry 151855, 1976).

30

The biosynthesis of isoprenoids such as cyclic terpenes is
said to be determined by key branch point enZymes referred
to as terpene synthases. The reactions catalyZed by terpene
synthases are complex, intramolecular cycliZations that may
involve several partial reactions. For example, the bioor
ganic rationale for the cycliZation of FPP by tWo sesquiter
pene synthases are shoWn in FIG. 3. In step 1, the initial
ioniZation of FPP is folloWed by an intramolecular electro

phillic attack betWeen the carbon bearing the diphosphate
moiety and the distal double bond to form germacene A, a
35

macrocylic intermediate. Internal ring closure and formation
of the eudesmane carbonium ion constitutes step 2. For

tobacco 5-epi-aristolochene synthase (TEAS), the terminal
step is a hydride shift, methyl migration, and deprotonation
at C9 giving rise to 5-epi-aristolochene as depicted in step
40

3a. Hyoscyamus muticus vetispiradiene synthase (HVS)
shares a common mechanism at steps 1 and 2, but differs

The common denominator for this diverse array of com

from TEAS in the third partial reaction in Which a ring

pounds is their universal ?ve-carbon building block, iso

contraction Would occur due to alternative migration of an

prene. The “biogenic isoprene rule” Was employed to ratio

naliZe the biosynthetic origins of all terpenoids derived from

the allyic substrates that can be accepted in initiating these
reactions. The synthases are also substrate speci?c.

HoWever, diverse sesquiterpene synthases, for example, can

particular, plant isoprenoids comprise a structurally diverse

primary and secondary metabolites (FIG. 1). Isoprenoids

mation betWeen tWo substrate molecules, Whereas the syn
thases catalyZe an intramolecular carbon-carbon bond for

very little variance in the stereochemistry or length of the

This invention relates to modi?ed isoprenoid synthase
enzymes, their encoding genes, and uses thereof.
The term isoprenoid is used to refer to a family of

monoterpene, sesquiterpene, and diterpene synthases or
synthases, and represent reactions committing carbon from
the general isoprenoid pathWay to end products in the
monoterpene, sesquiterpene, and diterpene classes, respec

electron pair. In each case, a monomeric protein of approxi
45

isoprene (RuZicka,Experientia 10:357, 1953). The polymer
iZation of tWo diphosphorylated isoprene building blocks

mately 64 kD catalyZes the complete set of partial reactions
and requires no cofactors other than Mg+2.

(e.g., IPP and dimethylallyl) generates geranyl diphosphate

SUMMARY OF THE INVENTION

(GPP), a linear C10 intermediate that can be converted to

In general, the invention features a chimeric isoprenoid
synthase polypeptide including a ?rst domain from a ?rst
isoprenoid synthase joined to a second domain from a

cyclic or linear end-products representing the monoterpenes,
or used in another round of polymeriZation. The addition of

second, heterologous isoprenoid synthase, Whereby the chi
meric isoprenoid synthase is capable of catalyZing the

a third isoprene unit to GPP generates farnesyl diphosphate
(FPP), Which can also be converted to cyclic or linear

products representing the sesquiterpene class. Continuing
the polymeriZation and chemical differentiation cycle leads
to the production of other classes of terpenoids named
according to the number of isoprene building blocks leading

55

heterologous isoprenoid synthase. In preferred
embodiments, the chimeric isoprenoid synthase is capable of

to their biosynthesis, for example, the addition of a third IPP

to FPP generates geranylgeranyl diphosphate (GGPP).
These polymeriZation reactions are catalyZed by prenyl
transferases that direct the attack of a carbocation (an
electron de?cient carbon atom resulting from the loss of the
diphosphate moiety of one substrate) to an electron-rich
carbon atom of the double bond on the IPP molecule (FIG.
2). The electrophilic nature of these reactions is said to be
unusual relative to more general nucleophilic condensation
reactions, but this appears to be a common reaction among

production of isoprenoid reaction products that are not
produced in the absence of the second domain of the second,

catalyZing at least tWo different isoprenoid reaction prod
ucts; the isoprenoid reaction products are cyclic; the second
60

domain of the second, heterologous isoprenoid synthase also
determines the ratio of the isoprenoid reaction products of
the chimeric isoprenoid synthase; the ?rst domain from the

65

?rst isoprenoid synthase is a plant isoprenoid synthase and
the second domain from the second, heterologous isoprenoid
synthase is also from a plant isoprenoid synthase.
Preferably, the chimeric isoprenoid synthase is chosen
from the group consisting of (a) the tobacco-Hyoscyamus

6,072,045
3

4

CH4 chimeric isoprenoid synthase; (b) the tobacco
Hyoscyamus CH10 chimeric isoprenoid synthase; (c) the
tobacco-Hyoscyamus CH11 chimeric isoprenoid synthase;
(d) the tobacco-Hyoscyamus CH12 chimeric isoprenoid
synthase; (e) the tobacco-Hyoscyamus CH13 chimeric iso
prenoid synthase; or
the tobacco-Hyoscyamus CH14

9118497, 1994; Chen et al., Arch. Biochem. Biophys.
3241255, 1994; and Cane et al., Biochemistry 3315846,

1994).
By “polypeptide” or “protein” is meant any chain of

amino acids, regardless of length or post-translational modi

?cation (for example, glycosylation or phosphorylation).

chimeric isoprenoid synthase, all as described herein.

In preferred embodiments, the chimeric isoprenoid syn
thase catalyzes the production of an isoprenoid reaction
product that is of agricultural, pharmaceutical, commercial,
or industrial signi?cance (e.g., an antifungal agent, antibac

By “joined to” is meant covalently bonded either directly
or indirectly (i.e., the domains are separated by an interven

ing amino acid sequence). Such domains may be bonded by
10

terial agent, or antitumor agent).
In other related aspects, the invention features DNA,

vectors, and cells (for example, E. coli, Saccharomyces
cerevisiae, animal or plant cells) encoding or containing a

By “domain” is meant a contiguous stretch of amino acids
Within a polypeptide or protein.
15

chimeric isoprenoid synthase polypeptide.

diterpenes, sesquiterpenes, and sterols. As described herein,

prenoid synthase polypeptide including an asymmetrically

isoprenoids are found in a variety of organisms, for example,
20

the chimeric polypeptide at a site Which differs from its

When the domain is positioned at its naturally-occurring site

position in the naturally-occurring polypeptide.

in the isoprenoid synthase polypeptide.
producing a chimeric isoprenoid synthase polypeptide, the
method involving: (a) providing a cell transformed With
DNA encoding a chimeric isoprenoid synthase positioned
for expression in the cell; (b) culturing the transformed cell
under conditions for expressing the DNA; and (c) recovering
the chimeric isoprenoid synthase.
By “isoprenoid synthase” is meant a polypeptide that is
capable of catalyzing a reaction involving the intramolecular

25

limitation, monoterpene synthases (for example, limonene
synthase), diterpene synthases (for example, casbene
synthase), and sesquiterpene synthases (for example, 5-epi
aristolochene synthase, vetispiradiene synthase, and

By “heterologous” is meant derived from different
sources (in this case, different polypeptides).
By “homologous” is meant derived from the same source

(in this case, the same polypeptide).
Other features and advantages of the invention Will be
30

apparent from the folloWing description of the preferred
embodiments thereof, and from the claims.
DETAILED DESCRIPTION

carbon-carbon bond formation of an allylic diphosphate

substrate (for example, a C10, C15, or C2O allylic diphosphate
substrate) to an isoprenoid product (for example, a
monoterpene, diterpene, sesquiterpene, or sterol product).
Examples of such isoprenoid synthases include, Without

animal, fungal, or bacterial sources.

By “asymmetrically positioned” is meant located Within

isoprenoid reaction products (preferably, cyclic products)
In another aspect, the invention features a method for

By “isoprenoid” is meant a compound that is derived from
an isoprene building block. In particular, isoprenoid com

pounds include, Without limitation, monoterpenes,

In another aspect, the invention features a chimeric iso

positioned homologous domain Whereby the chimeric iso
prenoid synthase is capable of catalyZing the production of

any means, including, Without limitation, a peptide bond or

chemical linkage.

The draWings Will ?rst be described.
35

DraWings
FIG. 1 is a schematic illustration shoWing the isoprenoid

biosynthetic pathWay With respect to the type of end prod
ucts and their respective physiological functions. Broken
40

arroWs indicate multiple steps or reactions.
FIG. 2 is a schematic illustration shoWing the various

reactions that are catalyZed by prenyltransferases and ter

pene synthases.

cadinene synthase) that are responsible for cycliZation of

FIG. 3 is a schematic illustration shoWing a reaction

geranyl diphosphate (GPP), farnesyl diphosphate (FPP), and
geranylgeranyl diphosphate (GGPP), respectively. Anumber

mechanism for the synthesis of eremophilane (tobacco
45

of terpene synthases from plant and microbial sources have
been isolated and characteriZed (see, for example, Moestra

erpene synthases. Partial reactions 1 and 2 are considered
common to both types of synthases. Mechanistic differences
in partial reactions 3a and 3b are sufficient to account for the

and West, Arch. Biochem. Biophys. 2381325, 1985; Hohn
and Van MiddlesWorth, Arch. Biochem. Biophys. 2511756,
1986; Hohn and Plattner,Arch. Biochem. Biophys. 2721137,
1989; Cane and Pargellis,Arch. Biochem. Biophys. 2541421,
1987; Munck and Croteau,Arch. Biochem. Biophys. 282158,
1990; Alonso et al.,J. Biol. Chem. 26717582, 1992; Savage

different reaction products shoWn.
FIG. 4A is a schematic illustration shoWing the chimeric
constructs used to map catalytic domains Within sesquiter

pene synthases. Line draWings depict composite diagrams

et al., J. Biol. Chem. 26914012, 1994; Croteau et al., Arch.

Biochem. Biophys. 3091184, 1994; Vogeli et al., Plant
Physiol. 931182, 1990; Guo et al., Arch. Biochem. Biophys.

5-epi-aristolochene synthase, TEAS) and vetispiradiene
(Hyoscyamus vetispiradiene synthase, HVS) type sesquit
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for Wildtype (i.e., TEAS and HVS) and chimeric
(CH1—CH14) sesquiterpene synthase genes that Were engi
neered into the bacterial expression vector pGBT-T19. Gene

3081103, 1994; and Gambliel and Croteau, J. Biol. Chem.

constructs Were prepared using a combination of the avail

2591740, 1984). In general, terpene synthases are soluble

able restriction endonuclease sites and ampli?cation of
select regions using PCR and PCR primers harboring con
venient restriction endonuclease sites. Correspondence
betWeen unique restriction endonuclease sites and amino

enZymes having a molecular Weight of about 40 to 100 kD.
Genes encoding a number of monoterpene, diterpene, and
sesquiterpene synthases have been described for a number of

60

plant and microbial organisms (see, for example, Hohn and
Beremand, Gene 791131, 1989; Proctor and Hohn, J. Biol.
Chem. 26814543, 1993; Facchini and Chappell, Proc. Natl.
Acad. Sci. 89111088, 1992; Back and Chappell, J. Biol.
Chem. 27017375, 1995; Colby et al., J. Biol. Chem.
268123016, 1993; Mau and West, Proc. Natl. Acad. Sci.

acid positions are noted.
FIG. 4B is a photograph of a TLC experiment shoWing

synthase enZyme activities in sonicated lysates of E. coli TB
65

1 cells expressing the TEAS, HVS, and chimeric synthase
constructs (CH1—CH14) and measured using 3H-FPP. Reac
tion products Were separated by argentation-TLC and
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detected by autoradiography. The radioactivity in 0.5 mm

fragment) With the 3‘ terminal portion of TEAS gene
(corresponding to the HindIII to KpnI fragment) into pGBT

segments of each lane of an argentation-TLC plate Was
determined in a scintillation counter, and radioactivity asso
ciated With the Zones for the TEAS and HVS speci?c
products Was set to 100%.
FIG. 5 is a schematic illustration shoWing the correspon
dence betWeen eXons and functional domains Within iso

T19.

CH7 Was prepared by ligating the 5‘ terminal portion of
the HVS gene (corresponding to the EcoRI to NdeI

fragment) With the 3‘ terminal portion of TEAS gene
(corresponding to the NdeI to KpnI fragment) into pGBT

prenoid synthases. The upper diagram represents the orga
niZation of eXons Within the TEAS gene, Which is nearly
identical to that of the HVS and casbene synthase genes. The

T19.

CH3, CH4, CH12, and CH13 Were constructed using
10

loWer diagram shoWs the alignment of functional domains to
the eXonic organiZation of the TEAS and HVS genes. EXon
numbers are shoWn Within the upper diagram, and all other
numbers refer to amino acid positions, some of Which
correspond to the noted restriction endonuclease sites.
FIG. 6 is a schematic diagram shoWing a domain sWitch

of particular segments of the HVS gene. To facilitate direc

tional cloning and maintenance of reading frame, primers
Were also designed to contain convenient restriction sites.
15

ing strategy used to generate a quiescent synthase (QH1).

the ClaI/KpnI fragment of the HVS gene. The HVS ClaI/

KpnI fragment Was prepared by PCR methodology using

eXon 4 into CH3 results in a synthase having an altered
20

FIG. 7 is a schematic diagram of a domain sWitching

strategy used for producing a chimeric quiescent-casbene

synthase, and possible reaction products.
FIG. 8 is a schematic illustration of a domain sWitching

strategy for producing a chimeric quiescent-cadinene

25

synthase, and possible reaction products.
Chimeric Isoprenoid Synthases
Plasmids designed for eXpressing a chimeric synthase
Were generated by substituting a portion of a gene encoding
a domain from tobacco 5-epi-aristolochene synthase With a
portion of a gene encoding a domain from Hyoscyamus

assays included an argentation-thin layer chromatography
(TLC) analysis Which distinguished the aristocholene and
vetispiradiene reaction products (Back and Chappell, J. Biol.

(SEQ ID NO:1) (ClaI restriction site underlined) as the
forWard primer and 5‘-d(AATACGACTCACTATAG)-3‘
(SEQ ID NO:2) as the reverse primer (corresponding to the
T7 sequence found in the multiple cloning site of pBSK)
using pBSK-HVS as the DNA template. The resulting
restriction fragment Was ligated into the EcoRI/KpnI sites of
the pGBT-T19 vector.
CH4 and CH13 Were constructed in a similar manner, but

30
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GTCAACATGGTTTATTGAGGGATA)-3‘ (SEQ ID N013)
(HincII restriction site underlined) and 5‘-d(TAT
TCTAGATCTCTATGACGATTATGAA)-3‘ (SEQ ID
NO:4) (XbaI restriction site underlined), respectively.
CH12 Was prepared by ligating a PCR fragment corre
sponding to the ?rst 1326 nucleotides of CH4 With the

ClaI/KpnI fragment of the TEAS gene into the EcoRI/KpnI
sites of the pGBT-T19 vector. The CH4 fragment Was

prepared using forWard ampli?cation primer 5‘-d

Chem. 270:7375, 1995). As shoWn in FIG. 4A, fourteen
chimeric synthase constructs Were generated and Were
assayed as folloWs.

5‘-d(GGGATCGATGACATAGCCACGTATGAGGTT)-3‘

using the forWard ampli?cation primers 5‘-d(CGA

vetispiradiene synthase. These plasmids Were eXpressed in
bacteria, and bacterial lysates Were prepared and assayed for

sesquiterpene synthase activity. The sesquiterpene synthase

CH3 Was constructed as folloWs. An EcoRI/ClaI restric

tion fragment of the TEAS gene Was isolated and ligated to

Substituting the inactive HVS domain corresponding to

enZyme activity.

conventional polymerase chain reaction (PCR)
methodologies, With primers designed for the ampli?cation

(G G G A G C T C
40

GAATTCCATGGCCTCAGCAGCAGTTGCAAACTNF)-3‘
(SEQ ID NO:5) (EcoRI restriction site underlined and

Full-length cDNAs for the tobacco 5-epi-aristolochene

translation start codon in bold) and reverse primer 5 ‘-d(GGG

synthase (TEAS) and Hyoscyamus vetispiradiene synthase

ATCGATAACTCTGCATAATGTAGCATT)-3‘ (SEQ ID
NO:6) (ClaI restriction site underlined).

(HVS) Were cloned into the EcoRI/XhoI sites of pBluescript

SK (Stratagene), creating the pBSK-TEAS and pBSK-HVS
plasmids, respectively (Back and Chappell, J. Biol. Chem.

45

270:7375, 1995). The TEAS and HVS cDNA inserts of these
expression plasmids Were oriented With their translation start
codons neighboring the EcoRI restriction site and their 3‘
poly A tail ?anked by the XhoI restriction site of the pSK

HindIII fragment of the HVS gene With the HindIII/KpnI
fragment of CH3 generated CH6. CH8 Was created by
ligating the EcoRI/NdeI fragment of HVS With the NdeI/
KpnI fragment of CH3. CH9 Was created by ligating the

plasmid.
Chimeric synthases CH1, CH2, CH5, and CH7 Were
constructed by utiliZing the conserved HindIII and NdeI
restriction sites found betWeen the tobacco and Hyoscyamus
genes. CH1 Was prepared by ligating the 5‘ terminal portion

EcoRI/NdeI fragment of CH5 With the NdeI/KpnI fragment
of HVS. CH10 Was constructed by ligating the EcoRI/

HindIII fragment of HVS With the HindIII/KpnI fragment of
55

of the TEAS gene (corresponding to the EcoRI to HindIII

fragment) With the 3‘ terminal portion of HVS gene
(corresponding to the HindIII to KpnI fragment) into the

bacterial eXpression vector pGBT-T19 (Gold
Biotechnology) predigested With EcoRI and KpnI.

Chimeric synthases CH6, CH8, CH9, CH10, CH11, and
CH14 Were constructed as folloWs. Ligation of the EcoRI/

CH4. CH11 Was constructed by ligating the EcoRI/NdeI
fragment of HVS With the NdeI/KpnI fragment of CH4. And
CH14 Was generated by substituting the EcoRI/NdeI frag
ment of CH13 With the corresponding DNA fragment of
pBSK-HVS. The nucleotide junctions of the chimeric con
structs Were con?rmed by double-stranded DNA sequencing

60

CH2 Was prepared by ligating the 5‘ terminal portion of

using the dideoXy nucleotide chain termination kit, accord
ing to the manufacturer’s instructions (U.S. Biochemical

the TEAS gene (corresponding to the EcoRI to NdeI

Corp).

fragment) With the 3‘ terminal portion of HVS gene
(corresponding to the NdeI to KpnI fragment) into pGBT

Chimeric synthases Were eXpressed in E. coli TB1 cells.
Procedures for groWth of the bacterial cells, induction of

T19.

CH5 Was prepared by ligating the 5‘ terminal portion of
the HVS gene (corresponding to the EcoRI to HindIII

65

gene expression, measurement of sesquiterpene synthase
enZyme activity, and the determination of total protein in the
bacterial lysates Were performed according to the methods
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described by Back and Chappell (Arch. Biochem. Biophys.
315:527, 1994; J. Biol. Chem. 270:7375, 1995). Reaction

442 Within the Hyoscyarnus protein are responsible for the

products Were separated by developing G60 silica TLC
plates impregnated With 15% silver nitrate in benZene:hex

HincII to ClaI fragment of the cDNA).
Our interpretation Was con?rrned by evaluating the
expression products of CH11 and CH12. CH11 represented

HVS-speci?c products (i.e., the region corresponding to the

ane:diethyl ether (50:50: 1). For qualitative evaluations, TLC
plates Were sprayed With Enhance surface ?uorography

the substitution of the NdeI to HincII fragment of the

spray (Dupont) and exposed to Kodak XAR-5 ?lm for 2 to
5 days at —70° C. For quantitative evaluations, 0.5 mm Zones

Hyoscyarnus gene With the corresponding tobacco gene
fragment, and resulted in the production of an enzyme
having HVS- and TEAS-speci?city. CH12 represented a

of an entire lane from a TLC plates Were scraped into

scintillation vials, and the radioactivity was determined
using a Packard 1500 Liquid Scintillation Counter. The

10

and TEAS-speci?city. Cornparing CH11 to CH13 provided
a further re?nernent in the domain characteriZation of the

CH14 constructs in bacterial lysates Were also veri?ed by

tobacco enZyrne responsible for the TEAS-speci?c products.

15 The fact that CH13 Was found to be a multifunctional

enZyrne indicated that the 81 amino acids encoded by the
DNA fragment residing betWeen the NdeI to XbaI restriction

(data not shoWn). In addition, mass spectra pro?les were

compared to that published for 5-epi-aristolochene (Anke
and Sterner, Planta Med. 57:344, 1991) and the predicted
fragrnentation pattern for vetispiradiene (EnZell et al., Mass
Spectrometry Rev. 3:395, 1984).
As shoWn in FIGS. 4A—B, the dominant reaction product
resulting from the expression of the tobacco TEAS gene
expressed Was 5-epi-aristolochene, and vetispiradiene Was
found to be the dominant reaction product resulting from the
expression of the HVS gene. The predominant reaction
products generated by the expression of CH1 and CH2 Were

sites of the tobacco cDNA Were sufficient for formation of

the predominant TEAS speci?c products. This interpretation
20

25

30

expressed from the pBSK-HVS plasrnid. These results indi

functionally equivalent With respect to the HVS carboxy
35

and the resulting synthase activity Was expected to result in

expression of a TEAS-speci?c product (i.e., 5-epi
aristolochene). Irnrnunodetection assays revealed that syn
thase protein produced upon expression of CH7 Was found
to be of the correct siZe and expected abundance (data not
shoWn); hoWever, no enzyme activity Was detected. The lack
of enzyme activity indicated that interactions betWeen the
carboxy and amino terminal portions of the protein contrib
uted to enzyme activity. This interpretation is further sup

40
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generated by the expression of the CH5 and CH6 constructs.
CH5 resulted in the expression of a product having a 10-fold

Biochem. Biophys. 315:527, 1994). GC and GC-MS analy

bicyclic sesquiterpene (20%) ([M]+ ion at rn/Z of 204). The
predominant HVS reaction product Was vetispiradiene
(>90%) ([M]+ ion at rn/Z of 204 With a base peak at rn/Z 41
and a series of predictable ions at rn/Z 175, 108, 94, and 68),
and the predominant reaction products of CH4 Were 5-epi

aristolochene (18%), a bicyclic sesquiterpene (43%), and

vetispiradiene (32%) (data not shoWn).

rnately 1% of the total products, With all 5 found at the same
relative abundance in all the reaction assays.
Ratio-Deterrninant Dornain

Another domain of the synthase proteins Was identi?ed by
comparing the relative ratio of the predominant reaction

loWer speci?c activity of synthase enzyme activity than the
other chirneric synthases, even though the absolute level of
expressed protein was similar to the other constructs (as

products produced by the rnultifunctional chirneric synthase
enZyrnes (FIG. 4A). For example, the reaction products
resulting from expression of constructs CH4, CH10, CH11,

determined by irnrnunodetection, data not shoWn). Substi
tuting an HVS carboxy-terrninal region Was found to restore
the speci?c activity to the synthase enzyme that Was gen

corresponding to the NdeI and ClaI restriction sites Within
the TEAS and HVS genes. Expression of CH4 unexpectedly
resulted in the production of a chimeric synthase protein

Chappell, J. Biol. Chem. 270:7375, 1995; Back et al.,Arch.

In addition, studies relying on affinity puri?cation of
histidine-tagged recornbinant synthase proteins has revealed
5 other minor reaction products, each representing approxi

ported by comparing the speci?c activity of the enzymes

erated by CH6.
Comparison of CH2 and CH3 chirneric synthases pro
vided evidence for speci?city of end-product forrnation
residing Within a domain of approximately 181 amino acids,

With that of the TEAS gene (FIG. 4A).
As shoWn in FIG. 4B, the predominant reaction product(s)
of the Wildtype tobacco TEAS and Hyoscyarnus HVS genes
expressed in bacteria rnigrated on silver nitrate-TLC plates
With Rf values of 0.41 and 0.31, values consistent With
previous characteriZation of these products as 5-epi

ses indicated that the predominant TEAS reaction products
Were 5-epi-aristolochene (70% of total products, based on
percentage of total peak areas from GC analysis) and a

cated that the amino-terminal half of TEAS and HVS Were

terrninus and do not contribute to the speci?city of the
reaction product. CH7, having an HVS amino terminus and
a TEAS carboxy terrninus, is the converse construct of CH2,

Was con?rrned by substituting the domain contained Within
the NdeI/XbaI HVS cDNA restriction fragment of CH14

aristolochene and vetispiradiene, respectively (Back and

also HVS-speci?c (i.e., vetispiradiene), with enzyme spe
ci?c activities similar to those found for HVS that Was

gene With the corresponding Hyoscyarnus gene fragment,
and resulted in the production of an enzyme having HVS

dominant reaction products generated by the synthase activi
ties resulting from expression of the TEAS, HVS, CH4, and
gas chromatography (GC) and gas chromatography-mass
spectroscopy (GC-MS) according to the conditions
described by Chappell et al. (Phytochemistry 26:225 9, 1987)

substitution of the HincII to ClaI fragment of the tobacco

and CH12 Were generated in a ratio of 60—70% TEAS
55

speci?c to 30—40% HVS-speci?c. In contrast, an inverse
ratio of reaction products resulted from expression of con
structs CH13 and CH14. This result indicated that the region
encompassed by the XbaI to HincII dornain in?uenced the

relative ratio of reaction products generated by the multi
60

functional chirneric synthase enZyrnes. These results indi
cated that tWo separate and distinct dornains Within the

capable of generating reaction products re?ective of both the

synthase peptide contributed directly to the types of reaction
products generated, and are interrupted by another domain

TEAS and HVS enZyrnes. We interpreted this result to
indicate that amino acids 261 to 379 Within the tobacco

Which We refer to as the ratio-deterrninant dornain (FIG. 5).

speci?c products (i.e., the region corresponding to the NdeI

Site-Directed Mutagenesis
Additional analysis of the product speci?city and ratio

to HincII fragment of the cDNA), While amino acids 379 to

deterrninant dornains was determined using conventional

5-epi-aristolochene synthase are responsible for the TEAS

65
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site-directed mutagenesis methodologies. The results of this
analysis are presented in Table I (below). For example, the
DDXXD motif, found Within the aristolochene speci?c

corresponding active domain of CH3, as outlined in FIG. 6.
CH3 contains an inactive domain corresponding to exon 6 of

TEAS, has convenient NdeI and XbaI restriction sites for the
desired substitution, and can be overexpressed in bacteria to

domain, is a conserved sequence that is found in a variety of

high levels. Domain sWitching is accomplished using stan

terpene biosynthetic enZymes including TEAS and HVS.

dard molecular techniques, as described herein. In one

This acidic amino acid cluster is said to coordinate a metal

particular example, a PCR ampli?cation product of HVS

cofactor that is necessary to neutraliZe the diphosphate
moiety of FPP in an otherWise lipophilic pocket. Substitu
tion of the ?rst aspartic acid residue (D301) of the DDXXD

motif With either glutamic acid (overall charge conservation)

10

or valine (net loss of acidic charge) residues (i.e., D301QE
and D301QV) resulted in the formation of an inactivated
enZyme. Aconserved substitution of the second aspartic acid

(D302) With a glutamic acid residue (i.e., D302—>E) also
inactivated chimeric synthase enZyme activity by 95%, and

cDNA corresponding to exon 4, encompassing amino acids
261 to 342 and containing appropriate NdeI and XbaI sites
Within the primers, is substituted for the corresponding
region of CH3. In generating such constructs, care is exer
cised to maintain appropriate amino acid residues and the
correct reading frame, and expression testing of the con
struct entails a measurement of the protein level in the

15

resulted in a slight alteration of the product distribution of
the multifunctional enZyme.

soluble and insoluble fractions of bacterial lysates by immu
noblotting techniques, as Well as by enZyme assays.
In addition, large scale enZyme reactions are performed,
the reaction product(s) are extracted into hexane, and the

TABLE I
Mutation

Mutated

target gene

amino acid

Product ratio

Speci?c Activity

Aristolochene

Vetispiradiene

66%

34%

34

49%

0
0
0
0
1.

CH4

(nmol/mg hi1)

Substrate binding domain (Ndel/Xbal region)
Tobacco
CH4
CH4
CH4
CH4

D301V
R287A
D301V
D301E
D302E

No
No
No
No

activity
activity
activity
activity
51%

Ratio determinant domain (Xbal/HincII region)
CH4

K347I

64%

36%

32

CH4
CH4

H3605
H3645

63%
65%

32%
35%

38

33%
32%
33%
30%
39%

48
29
30
32
33

29

Hyoscyamus speci?c domain (HincII/ClaI region)
CH4
CH4
CH4
CH4
CH4

T408A
K420M
H422A
N436S
AT437, 438VI

67%
68%
67%
70%
61%

products are puri?ed by HPLC methods. Additional evalu
ation of the quiescent enZyme reaction products is carried

The sites for directed substitutions Within the ratio

determinant domain (i.e., K347QI, H360QS, H364QS)

Were inferred by an analysis of reports that hypothesiZed the 45 out using TLC, and comparing the Rf values of the experi

importance of charged amino acid residues (e.g., histidine or

mental sample to those generated by the TEAS and HVS
enZymes. Retention times of the reaction products (e.g.,

lysine) in synthase enZymology, and these sites represented

those amino acids Which displayed the greatest charge
germacrene or germacrene-like reaction product) are also
differences in comparisons betWeen the TEAS and HVS
monitored using GC, GC-MS, and NMR according to stan
primary sequences. None of the three mutations analyzed 50 dard methods.
had any effect on overall catalytic activity or the ratio of

The quiescent synthase is useful for providing suf?cient
amounts of the germacrene reaction intermediate(s) (or
derivatives thereof) to con?rming the chemical rationaliZa
tion for the EAS and VS reactions, and produces a template

products formed.
Amino acid substitutions Within the HVS speci?c domain
Were chosen on the basis of comparisons betWeen secondary
structural predictions of the HVS and TEAS proteins. Those
amino acids mutated appeared to contribute disproportion
ately to structural distortions in the secondary structure

55

models of these tWo proteins, largely because of charge

Chimeric Casbene and Cadinene Synthases
Chimeric isoprenoid synthases are also useful for gener

considerations. HoWever, as shoWn in Table I (above),

substitutions involving charged to non-charged (i.e.,
T408—>A, K420QM, H422—>A) or reduced charged
(N436—>S, A437QT, V438—>I) amino acids did not affect

60

or the other.

To generate a quiescent synthase, the inactive domain
corresponding to exon 4 of HVS is substituted With the

ating novel macrocyclic isoprenoids or isoprenoids having
altered stereochemical properties. For example, isoprenoid
synthases such as casbene synthase, a diterpene synthase
Which catalyZes the synthesis of a macrocyclic diterpene

overall enZyme activity, nor the synthesis rate of one product

Quiescent Synthases

chimeric synthase that may be used for the introduction of
novel terminal steps in the overall synthase reaction scheme.

harboring a cyclopropyl side group, and cadiene synthase, a
65

sesquiterpene synthase that catalyZes the synthesis of a

bicyclic sesquiterpene, provide domains useful for engineer
ing enZymes capable of producing macrocylic isoprenoids or

6,072,045
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isoprenoid reaction products having altered sterochemical
properties. A general scheme for producing such chimeric

example, as described in Ausubel et al. (supra), or they may
be obtained from commercial sources.

synthases is presented in FIGS. 7 and 8.
To construct such chimeric casbene and cadienne

As discussed above, synthase oligonucleotides may also
be used as primers in ampli?cation cloning strategies, for

synthases, quiescent amino terminal domains (and other

example, using PCR. PCR methods are Well knoWn in the art

synthase domains as necessary) are substituted With those

and are described, for example, in PCR Technology, Erlich,
ed., Stockton Press, London, 1989; PCR Protocols.'A Guide
to Methods and Applications, Innis et al., eds., Academic
Press, Inc., NeW York, 1990; and Ausubel et al. (supra).
Primers are optionally designed to alloW cloning of the
ampli?ed product into a suitable vector, for example, by

from casbene and cadinene synthase using convenient
restriction sites and PCR ampli?cation of selected regions as
described above. Sequences corresponding to the
N-terminal, plastid targeting sequence of the casbene syn

10

thase are deleted in these constructs. Chimeric constructs are

expressed in bacteria, bacterial lysates are examined for
chimeric synthase activity, and reaction products are char
acteriZed as described above, for example, using
argentation-TLC. Constructs supporting high levels of syn

including appropriate restriction sites at the 5‘ and 3‘ ends of

the ampli?ed fragment (as described herein). If desired, a
15

thase activity in bacteria and/or activity generating reaction
products Which migrate With Rns different from aris
tolochene and vetispiradiene standards are considered useful
in the invention. Reaction products are also analyZed for
their retention times by GC and subjected to GC-MS and
NMR, as necessary. Those domains of casbene synthase and
cadinene synthase Which contribute to the synthesis of
unique reaction products may also be subjected to ?ne detail

Innis et al. (supra)). By this method, oligonucleotide primers
based on a synthase sequence are oriented in the 3‘ and 5‘

20

25

Production of Other Chimeric Isoprenoid Synthases
Using the standard molecular techniques described
herein, other chimeric synthases may be readily generated

directions and are used to generate overlapping PCR frag
ments. These overlapping 3‘- and 5‘-end RACE products are
combined to produce an intact full-length cDNA. This
method is described in Innis et al. (supra); and Frohman et

al., Proc. Natl. Acad. Sci. USA 85:8998, (1988).

mapping using a strategy analogous to that depicted in FIG.
4A.

synthase gene may be isolated using the PCR “RACE”
technique, or Rapid Ampli?cation of cDNA Ends (see, e.g.,

Useful synthase sequences may be isolated from any
appropriate organism. Con?rmation of a sequence’s relat
edness to the synthase polypeptide family may be accom
plished by a variety of conventional methods, for example,
sequence comparison. In addition, the activity of any syn
thase protein may be evaluated according to any of the
techniques described herein.

30

Which include domains from knoWn or neWly isolated

Chimeric Isoprenoid Synthase Polypeptide

synthase enZymes. Such chimeric synthases may be tested

Expression

for activity using, for example, any appropriate enZyme

Chimeric synthase polypeptides may be produced by

assays knoWn to those in the art, or by standard immuno

detection techniques.

35

The isolation of additional synthase coding sequences is

transformation of a suitable host cell With all or part of a

chimeric synthase DNA (for example, the chimeric synthase

also possible using standard cloning strategies and tech

cDNAs described above) in a suitable expression vehicle or

niques that are Well knoWn in the art. For example, using all

With a plasmid construct engineered for increasing the
expression of a chimeric synthase polypeptide in vivo.
Those skilled in the ?eld of molecular biology Will
appreciate that any of a Wide variety of expression systems
may be used to provide the recombinant protein. The precise

or a portion of the amino acid sequence of a knoWn synthase

polypeptide, one may readily design synthase-speci?c oli

40

gonucleotide probes, including synthase degenerate oligo
nucleotide probes (i.e., a mixture of all possible coding
sequences for a given amino acid sequence). These oligo

host cell used is not critical to the invention. The chimeric

nucleotides may be based upon the sequence of either DNA

strand and any appropriate portion of synthase nucleotide
sequence. General methods for designing and preparing
such probes are provided, for example, in Ausubel et al.,
1996, Current Protocols in Molecular Biology, Wiley
Interscience, NeW York, and Berger and Kimmel, Guide to
Molecular Cloning Techniques, 1987, Academic Press, NeW

45

synthase protein may be produced in a prokaryotic host, for
example, E. coli TB1, or in a eukaryotic host, for example,

Saccharomyces cerevisiae, mammalian cells (for example,
COS 1 or NIH 3T3 cells), or any of a number of plant cells

including, Without limitation, algae, tree species, ornamental
species, temperate fruit species, tropical fruit species, veg
etable species, legume species, monocots, dicots, or in any

York. These oligonucleotides are useful for synthase gene
isolation, either through their use as probes capable of

plant of commercial or agricultural signi?cance. Particular
examples of suitable plant hosts include, but are not limited

hybridiZing to a synthase complementary sequences or as

to, Conifers, Petunia, Tomato, Potato, Tobacco, Arabidopsis,
Lettuce, Sun?oWer, Oilseed rape, Flax, Cotton, Sugarbeet,

primers for various ampli?cation techniques, for example,
polymerase chain reaction (PCR) cloning strategies.
Hybridization techniques and screening procedures are
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Well knoWn to those skilled in the art and are described, for

example, in Ausubel et al. (supra); Berger and Kimmel
(supra); Chen at al.Arch. Biochem. Biophys. 3241255, 1995;
and Sambrook et al., Molecular Cloning: A Laboratory
Manual, Cold Spring Harbor Laboratory Press, NeW York. If
desired, a combination of different oligonucleotide probes

MaiZe, Millet, Onion, Barley, Orchard grass, Oat, Rye, and
Wheat.
60

Such cells are available from a Wide range of sources

including: the American Type Culture Collection (Rockland,
Md.); or from any of a number seed companies, for example,

may be used for the screening of a recombinant DNA library.

W. Atlee Burpee Seed Co. (Warminster, Pa.), Park Seed Co.

The oligonucleotides may be detectably-labeled using meth
ods knoWn in the art and used to probe ?lter replicas from

Celery, Soybean, Alfalfa, Medicago, Lotus, Vigna,
Cucumber, Carrot, Eggplant, Cauli?oWer, Horseradish,
Morning Glory, Poplar, Walnut, Apple, Asparagus, Rice,

65

(Greenwood, SC), Johnny Seed Co. (Albion, Me.), or
Northrup King Seeds (Harstville, S.C.). Descriptions and

a recombinant DNA library. Recombinant DNA libraries are

sources of useful host cells are also found in Vasil I. K., Cell

prepared according to methods Well knoWn in the art, for

Culture and Somatic Cell Genetics of Plants, Vol I, II, III
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Laboratory Procedures and Their Applications Academic
Press, NeW York, 1984; Dixon, R. A., Plant Cell Culture—A
Practical Approach, IRL Press, Oxford University, 1985;

charomyces cerevisiae, are described, e.g., in Ausubel et al.

(supra); Weissbach and Weissbach, Methods for Plant
Molecular Biology, Academic Press, 1989; Gelvin et al.,
Plant Molecular Biology Manual, KluWer Academic
Publishers, 1990; Kindle, K., Proc. Natl. Acad. Sci. U.S.A.
87:1228 (1990); Potrykus, I., Annu. Rev. Plant Physiol.
Plant Mol. Biology 421205 (1991); and BioRad (Hercules,
Calif.) Technical Bulletin #1687 (Biolistic Particle Delivery
Systems). Expression vehicles may be chosen from those

Green et al., Plant Tissue and Cell Culture, Academic Press,
NeW York, 1987; and Gasser and Fraley, Science 244:1293,

(1989).
For prokaryotic expression, DNA encoding a chimeric
synthase polypeptide is carried on a vector operably linked

to control signals capable of effecting expression in the
prokaryotic host. If desired, the coding sequence may

10

contain, at its 5‘ end, a sequence encoding any of the knoWn

signal sequences capable of effecting secretion of the
expressed protein into the periplasmic space of the host cell,
thereby facilitating recovery of the protein and subsequent
puri?cation. Prokaryotes most frequently used are various

provided, e.g., in Cloning Vectors.'A Laboratory Manual (P.
H. PouWels et al., 1985, Supp. 1987); Gasser and Fraley

(supra); Clontech Molecular Biology Catalog (Catalog
15

1992/93 Tools for the Molecular Biologist, Palo Alto,
Calif.); and the references cited above.
One preferred eukaryotic expression system is the mouse

strains of E. coli,‘ hoWever, other microbial strains may also

3T3 ?broblast host cell transfected With a pMAMneo

be used. Plasmid vectors are used Which contain replication

expression vector (Clontech). pMAMneo provides: an RSV

origins, selectable markers, and control sequences derived
from a species compatible With the microbial host.

LTR enhancer linked to a dexamethasone-inducible MMTV

Examples of such vectors are found in PouWels et al. (supra)

20

or Ausubel et al. (supra). Commonly used prokaryotic
control sequences (also referred to as “regulatory elements”)
are de?ned herein to include promoters for transcription

initiation, optionally With an operator, along With ribosome
binding site sequences. Promoters commonly used to direct
protein expression include the beta-lactamase

expression. The recombinant chimeric synthase polypeptide
25

is then isolated as described beloW. Other preferable host

cells Which may be used in conjunction With the pMAMneo
expression vehicle include COS cells and CHO cells (AT CC
Accession Nos. CRL 1650 and CCL 61, respectively).

(penicillinase), the lactose (lac), the tryptophan (Trp)
(Goeddel et al., Nucl. Acids Res. 814057 (1980)), and the tac
promoter systems, as Well as the lambda-derived PL pro

moter and N-gene ribosome binding site (Simatake et al.,
Nature 292:128 (1981)).
One particular bacterial expression system for chimeric
synthase polypeptide production is the E. coli pET expres
sion system (Novagen). According to this expression
system, DNA encoding a chimeric synthase polypeptide is

LTR promotor, an SV40 origin of replication Which alloWs
replication in mammalian systems, a selectable neomycin
gene, and SV40 splicing and polyadenylation sites. DNA
encoding a chimeric synthase polypeptide is inserted into the
pMAMneo vector in an orientation designed to alloW

Alternatively, if desired, a chimeric synthase polypeptide
30

is produced by a stably-transfected mammalian cell line. A
number of vectors suitable for stable transfection of mam
malian cells are available to the public, e.g., see PouWels et

al. (supra); methods for constructing such cell lines are also
publicly available, e.g., in Ausubel et al. (supra). In one
35

example, cDNAencoding the chimeric synthase polypeptide

inserted into a pET vector in an orientation designed to alloW

is cloned into an expression vector Which includes the

expression. Since the chimeric synthase gene is under the
control of the T7 regulatory signals, expression of chimeric
synthase is induced by inducing the expression of T7 RNA
polymerase in the host cell. This is typically achieved using
host strains Which express T7 RNA polymerase in response
to IPTG induction. Once produced, recombinant chimeric
synthase polypeptide is then isolated according to standard
methods knoWn in the art, for example, those described

dihydrofolate reductase (DHFR) gene. Integration of the
plasmid and, therefore, the chimeric synthase-encoding gene
40

herein.

45

al. (supra); such methods generally involve extended culture
in medium containing gradually increasing levels of meth
otrexate. DHFR-containing expression vectors commonly

Another bacterial expression system for chimeric syn

thase polypeptide production is the pGEX expression system
(Pharmacia). This system employs a GST gene fusion sys
tem that is designed for high-level expression of a gene or
gene fragment as a fusion protein With rapid puri?cation and
recovery of the functional gene product. The chimeric

used for this purpose include pCVSEII-DHrF and

pAdD26SV(A) (described in Ausubel et al., supra). Any of
the host cells described above or, preferably, a DHFR

synthase protein of interest is fused to the carboxyl terminus
of the glutathione S-transferase protein from Schistosoma

japonicum and is readily puri?ed from bacterial lysates by
af?nity chromatography using Glutathione Sepharose 4B.

into the host cell chromosome is selected for by inclusion of
0.01—300 uM methotrexate in the cell culture medium (as
described in Ausubel et al., supra). This dominant selection
can be accomplished in most cell types. Recombinant pro
tein expression can be increased by DHFR-mediated ampli
?cation of the transfected gene. Methods for selecting cell
lines bearing gene ampli?cations are described in Ausubel et

de?cient CHO cell line (for example, CHO DHFR cells,

55

ATCC Accession No. CRL 9096) are among the host cells
preferred for DHFR selection of a stably-transfected cell line
or DHFR-mediated gene ampli?cation.

Fusion proteins can be recovered under mild conditions by

A chimeric synthase polypeptide is preferably produced

elution With glutathione. Cleavage of the glutathione

by a stably-transfected plant cell line or by a transgenic
plant. Anumber of vectors suitable for stable transfection of
plant cells or for the establishment of transgenic plants are

S-transferase domain from the fusion protein is facilitated by
the presence of recognition sites for site-speci?c proteases
upstream of this domain. For example, proteins expressed in
pGEX-2T plasmids may be cleaved With thrombin; those
expressed in pGEX-3X may be cleaved With factor Xa.
For eukaryotic expression, the method of transformation

60

lines are described in, e.g., Weissbach and Weissbach

(supra), and Gelvin et al. (supra). Typically, plant expression

or transfection and the choice of vehicle for expression of

the chimeric synthase polypeptide Will depend on the host
system selected. Transformation and transfection methods of
numerous organisms, for example, the baker’s yeast Sac

available to the public; such vectors are described in Pou

Wels et al. (supra), Weissbach and Weissbach (supra), and
Gelvin et al. (supra). Methods for constructing such cell
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vectors include (1) a cloned chimeric synthase gene under
the transcriptional control of 5‘ and 3‘ regulatory sequences

and (2) a dominant selectable marker. Such plant expression

6,072,045
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vectors may also contain, if desired, a promoter regulatory
region (for example, one conferring inducible or constitutive
expression, or environmentally- or developmentally

For certain applications, it may be desirable to produce
the chimeric synthase gene product in an appropriate tissue,

regulated, or pathogen- or Wound-inducible, or cell- or

time. For this purpose, there are an assortment of gene

tissue-speci?c expression), a transcription initiation start

promoters, each With its oWn distinct characteristics embod

site, a ribosome binding site, an RNA processing signal, a

ied in its regulatory sequences, shoWn to be regulated in

at an appropriate level, or at an appropriate developmental

response to the environment, hormones, and/or developmen

transcription termination site, and/or a polyadenylation sig
nal.
The chimeric synthase DNA sequence of the invention
may, if desired, be combined With other DNA sequences in
a variety of Ways. The chimeric synthase DNA sequence of
the invention may be employed With all or part of the gene

tal cues. These include gene promoters that are responsible
10

for heat-regulated gene expression (see, e.g., Callis et al.,
Plant Physiol. 88:965 (1988); Takahashi and Komeda, Mol.
Gen. Genet. 219:365 (1989); and Takahashi et al. Plant J.

2:751(1992)), light-regulated gene expression (e.g., the pea
rbcS-3A described by Kuhlemeier et al. (Plant Cell 1:471

sequences normally associated With a synthase protein. In its

transcription and translation in a host cell.

(1989); the maiZe rbcS promoter described by Schaffner and
Sheen, (Plant Cell 3:997 (1991); or the chlorophyll a/b
binding protein gene found in pea described by Simpson et
al. (EMBO J. 4:2723 (1985)), hormone-regulated gene

In general, the constructs Will involve regulatory regions
functional in plants Which provide for production of a

sequences from the Em gene of Wheat described by Marcotte
et al. (Plant Cell 1:969 (1989); the ABA-inducible HVA1

component parts, a DNA sequence encoding a chimeric
synthase protein is combined in a DNA construct having a

15

transcription initiation control region capable of promoting

chimeric synthase protein as discussed herein. The open

expression (for example, the abscisic acid (ABA) responsive
20

and HVA22, and the rd29A promoters described for barley
and Arabidopsis by Straub et al. (Plant Cell 6:617 (1994),
Shen et al. (Plant Cell 7:295 (1994)), and Wound-induced

reading frame coding for the chimeric synthase protein or
functional fragment thereof Will be joined at its 5‘ end to a

transcription initiation regulatory region such as the
sequence naturally found in the 5‘ upstream region of a
synthase structural gene. Numerous other transcription ini
tiation regions are available Which provide for constitutive

gene expression (for example, of WunI described by SiebertZ
25

et al. (Plant Cell 1:961 (1989)), or organ-speci?c gene

expression (for example, of the tuber-speci?c storage pro
tein gene described by Roshal et al. (EMBO J. 6:1155
(1987); the 23-kDa Zein gene from maiZe described by
Schernthaner et al. (EMBO J. 7:1249 (1988); or the French
bean [3-phaseolin gene described by Bustos et al. (Plant Cell

or inducible regulation.

For applications When developmental, cell, tissue,
hormonal, environmental, or pathogen-inducible expression
are desired, appropriate 5‘ upstream non-coding regions are

1:839 (1989)); and pathogen-inducible gene expression

obtained from other genes; for example, from genes regu

described by Chappell et al. in US. Ser. Nos. 08/471,983,

lated during seed development, embryo development, leaf

08/443,639, and 08/577,483, hereby incorporated by refer

development, or in response to a pathogen.

ence.

Regulatory transcript termination regions may also be

35

Plant expression vectors may also optionally include

provided in DNA constructs of this invention as Well.

RNA processing signals, for example, introns, Which have

Transcript termination regions may be provided by the DNA

been shoWn to be important for efficient RNA synthesis and
accumulation (Callis et al., Genes and Dev. 1:1183 (1987)).
The location of the RNA splice sequences can dramatically
in?uence the level of transgene expression in plants. In vieW
of this fact, an intron may be positioned upstream or
doWnstream of a chimeric synthase polypeptide-encoding

sequence encoding a synthase protein or any convenient
transcription termination region derived from a different
gene source. The transcript termination region Will contain
preferably at least 1—3 kb of sequence 3‘ to the structural
gene from Which the termination region is derived. Such
genetically-engineered plants are useful for a variety of
industrial and agricultural applications as discussed beloW.
Importantly, this invention is applicable to gymnosperms
and angiosperms, and Will be readily applicable to any neW
or improved transformation or regeneration method.
An example of a useful plant promoter according to the
invention is a caulimovirus promoter, for example, a cauli

40
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tory control regions Which are generally present in the 3‘
regions of plant genes (Thornburg et al., Proc. Natl. Acad.
Sci. USA. 84:744 (1987); An et al., Plant Cell 1:115
(1989)). For example, the 3‘ terminator region may be
included in the expression vector to increase stability of the
mRNA. One such terminator region may be derived from the
PI-II terminator region of potato. In addition, other com

?oWer mosaic virus (CaMV) promoter. These promoters
confer high levels of expression in most plant tissues, and
the activity of these promoters is not dependent on virally
encoded proteins. CaMV is a source for both the 35S and

19S promoters. In most tissues of transgenic plants, the
CaMV 35S promoter is a strong promoter (see, e.g., Odell et

monly used terminators are derived from the octopine or
55

al., Nature 313:810 (1985)). The CaMV promoter is also
highly active in monocots (see, e.g., Dekeyser et al., Plant
Cell 2:591 (1990); Terada and Shimamoto,M0l. Gen. Genet.
220:389, (1990)). Moreover, activity of this promoter can be

further increased (i.e., betWeen 2—10 fold) by duplication of

nopaline synthase signals.
The plant expression vector also typically contains a
dominant selectable marker gene used to identify those cells
that have become transformed. Useful selectable genes for

60

the CaMV 35S promoter (see e.g., Kay et al., Science
236:1299 (1987); OW et al., Proc. Natl. Acad. Sci. USA.
84:4870 (1987); and Fang et al., Plant Cell 1:141 (1989)).

Other useful plant promoters include, Without limitation,
the nopaline synthase promoter (An et al., Plant Physiol.

sequence in the transgene to modulate levels of gene expres
sion.
In addition to the aforementioned 5‘ regulatory control
sequences, the expression vectors may also include regula

plant systems include genes encoding antibiotic resistance
genes, for example, those encoding resistance to

hygromycin, kanamycin, bleomycin, G418, streptomycin, or
spectinomycin. Genes required for photosynthesis may also
be used as selectable markers in photosynthetic-de?cient

strains. Alternatively, the green-?uorescent protein from the
65

jelly?sh Aequorea victoria may be used as a selectable

88:547 (1988)) and the octopine synthase promoter (Fromm

marker (Sheen et al., Plant J. 8:777, 1995; Chiu et al.,

et al., Plant Cell 1:977 (1989)).

Current Biology 6:325 (1996)). Finally, genes encoding

6,072,045
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herbicide resistance may be used as selectable markers;
useful herbicide resistance genes include the bar gene

that Will function in plants, for example, a gene encoding
kanamycin resistance or herbicide resistance. Also present

encoding the enZyme phosphinothricin acetyltransferase and

on the vector are restriction endonuclease sites for the
addition of one or more transgenes and directional T-DNA

conferring resistance to the broad spectrum herbicide

Basta® (Hoechst AG, Frankfurt, Germany).

border sequences Which, When recogniZed by the transfer
functions of Agrobacterium, delimit the DNA region that

Efficient use of selectable markers is facilitated by a
determination of the susceptibility of a plant cell to a
particular selectable agent and a determination of the con

centration of this agent Which effectively kills most, if not
all, of the transformed cells. Some useful concentrations of
antibiotics for tobacco transformation include, e.g., 75—100

Will be transferred to the plant.

10

In another example, plant cells may be transformed by
shooting into the cell tungsten microprojectiles on Which
cloned DNA is precipitated. In the Biolistic Apparatus

(Bio-Rad) used for the shooting, a gunpoWder charge (22

pig/ml (kanamycin), 20—50 pig/ml (hygromycin), or 5—10

caliber PoWer Piston Tool Charge) or an air-driven blast

pig/ml (bleomycin). Auseful strategy for selection of trans
formants for herbicide resistance is described, e.g., by Vasil

drives a plastic macroprojectile through a gun barrel. An
aliquot of a suspension of tungsten particles on Which DNA
has been precipitated is placed on the front of the plastic
macroprojectile. The latter is ?red at an acrylic stopping
plate that has a hole through it that is too small for the
macroprojectile to pass through. As a result, the plastic

et al., supra.
It should be readily apparent to one skilled in the art of

molecular biology, especially in the ?eld of plant molecular
biology, that the level of gene expression is dependent, not
only on the combination of promoters, RNA processing
signals, and terminator elements, but also on hoW these

15
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elements are used to increase the levels of selectable marker

gene expression.

DNA introduced into the cell on the microprojectiles
becomes integrated into either the nucleus or the chloroplast.

Plant Transformation
25

Upon construction of the plant expression vector, several

have become major tools to carry out gene expression

studies in plants and to produce improved plant varieties of
agricultural or commercial interest.
30

tenstein and Fuller In: Genetic Engineering, vol 6, PW]

Transgenic Plant Regeneration

Rigby, ed, London, Academic Press, 1987; and Lichtenstein,

Plants cells transformed With plant expression vectors can

C. P., and Draper, J,. In: DNA Cloning, Vol II, D. M. Glover,

be regenerated, for example, from single cells, callus tissue,

ed, Oxford, IRI Press, 1985)), (2) the particle delivery
system (see, e.g., Gordon-Kamm et al., Plant Cell 2:603

In general, transfer and expression of transgenes in plant
cells are noW routine practices to those skilled in the art, and

standard methods are available for introduction of the vector

into a plant host, thereby generating a transgenic plant.
These methods include (1) Agrobacterium-mediated trans
formation (A. tumefaciens or A. rhizogenes) (see, e.g., Lich

macroprojectile smashes against the stopping plate, and the
tungsten microprojectiles continue toWard their target
through the hole in the plate. For the present invention, the
target can be any plant cell, tissue, seed, or embryo. The

35

(1990); or BioRad Technical Bulletin 1687, supra), (3)

or leaf discs according to standard plant tissue culture
techniques. It is Well knoWn in the art that various cells,
tissues, and organs from almost any plant can be success

microinjection protocols (see, e.g., Green et al., supra), (4)
polyethylene glycol (PEG) procedures (see, e.g., Draper et

fully cultured to regenerate an entire plant; such techniques

Physiol. 25 :1353 (1984)), (6) electroporation protocols (see,

are described, e.g., in Vasil supra; Green et al., supra;
Weissbach and Weissbach, supra; and Gelvin et al., supra.
In one particular example, a cloned chimeric synthase
polypeptide under the control of the EAS4 promoter and the

e.g., Gelvin et al., supra; Dekeyser et al., supra; Fromm et

nopaline synthase terminator and carrying a selectable

al., Plant Cell Physiol. 23:451 (1982); or e.g., Zhang and

Wu, Them’. Appl. Genet. 76:835 (1988)), (5) liposome

40

mediated DNA uptake (see, e.g., Freeman et al., Plant Cell

al., Nature 319:791 (1986); Sheen, Plant Cell 2:1027
(1990); or Jang and Sheen Plant Cell 6:1665 (1994)), and (7)
the vortexing method (see, e.g., Kindle supra). The method

marker (for example, kanamycin resistance) is transformed
45

of transformation is not critical to the present invention. Any
method Which provides for efficient transformation may be

into Agrobacterium. Transformation of leaf discs (for
example, of tobacco leaf discs), With vector-containing
Agrobacterium is carried out as described by Horsch et al.

(Science 227:1229 (1985)). Putative transformants are
selected after a feW Weeks (for example, 3 to 5 Weeks) on

employed. As neWer methods are available to transform

plant tissue culture media containing kanamycin (e.g., 100

crops or other host cells, they may be directly applied.
The folloWing is an example outlining one particular
technique, an Agrobacterium-mediated plant transforma

pig/ml). Kanamycin-resistant shoots are then placed on plant

tion. By this technique, the general process for manipulating

Kanamycin-resistant plants are then selected for greenhouse
groWth. If desired, seeds from self-fertiliZed transgenic

genes to be transferred into the genome of plant cells is
carried out in tWo phases. First, cloning and DNA modi?
cation steps are carried out in E. coli, and the plasmid
containing the gene construct of interest is transferred by

conjugation or electroporation into Agrobacterium. Second,
the resulting Agrobacterium strain is used to transform plant
cells. Thus, for the generaliZed plant expression vector, the
plasmid contains an origin of replication that alloWs it to
replicate in Agrobacterium and a high copy number origin of
replication functional in E. coli. This permits facile produc
tion and testing of transgenes in E. coli prior to transfer to

Agrobacterium for subsequent introduction into plants.
Resistance genes can be carried on the vector, one for

selection in bacteria, for example, streptomycin, and another

tissue culture media Without hormones for root initiation.
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plants can then be soWed in soil-less medium and groWn in
a greenhouse. Kanamycin-resistant progeny are selected by
soWing surfaced steriliZed seeds on hormone-free

kanamycin-containing media. Analysis for the integration of
the transgene is accomplished by standard techniques (see,
60
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for example, Ausubel et al. supra; Gelvin et al. supra).
Transgenic plants expressing the selectable marker are
then screened for transmission of the transgene DNA by
standard immunoblot and DNA detection techniques. Each

positive transgenic plant and its transgenic progeny are
unique in comparison to other transgenic plants established
With the same transgene. Integration of the transgene DNA
into the plant genomic DNA is in most cases random, and the

